2010年2月5日 · Advancing a pipeline of therapeutics built from our platform. Schrödinger’s therapeutics group strives to reduce risk in drug discovery and development by selecting high-value targets with established human genetics or clinical validation, where we can solve a design challenge, and where we believe we can deliver value for patients.

Our physics-based computational platform integrates differentiated solutions for predictive modeling, data analytics, and collaboration to enable rapid exploration of chemical space.

Complete modeling environment for your molecular discovery. Discover better quality molecules, faster. Maestro is Schrödinger’s streamlined portal for access to state-of-the-art predictive computational modeling and machine learning workflows for molecular discovery.

Benefits. Schrödinger provides a best-in-class work environment with competitive salaries, stock options, professional growth opportunities, and excellent benefits, including over a month of paid vacation.

We are driven to be the world leader in transforming drug discovery and materials design by relentlessly pursuing scientific and technology breakthroughs.; We are committed to achieving the best possible outcomes for our customers, partners, patients, and other stakeholders.; We deeply value our dedicated employees and invest in their growth, development, and well-being.

2024年12月17日 · To opt-in for investor email alerts, please enter your email address in the field and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.

2024年10月3日 · Materials Science Content Library. Discover, optimize, and formulate the materials of the future with our predictive computational platform.

SGR-3515 is a Wee1 G2 Checkpoint Kinase and Membrane Associated Tyrosine/Threonine 1 (Wee1/Myt1) inhibitor. Wee1 is a gatekeeper checkpoint kinase that prevents cellular progression through the cell cycle, allowing time for DNA repair before cell division takes place.

Level-up your research with molecular modeling training resources, curated by Schrödinger Education experts.

Proprietary Pipeline Highlights. SGR-1505 (MALT1) SGR-1505 is a mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor. SGR-2921 (CDC7) SGR-2921 is a cell division cycle 7-related protein kinase (CDC7) inhibitor. SGR-3515 (Wee1/Myt1) SGR-3515 is a Wee1/Myt1 inhibitor.